Vanta Bioscience Cash Flow Annual

Trade
BSE: 540729 | NSE: - | ISIN: INE695X01011 | Sector: Biotechnology & Drugs
47.32 +2.16 (4.78%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line -8.83-10.260.230.59
Depreciation/ Depletion 4.502.671.321.25
Non- Cash Items 5.715.892.352.12
Changesin Working Capital 1.311.081.332.91
Cashfrom Operating Activities 2.68-0.635.226.87
Capital Expenditures -3.40-28.69-17.18-22.19
Other Investing Cash Flow Items Total 0.0922.78-0.00
Cashfrom Investing Activities -3.31-5.91-17.18-22.19
Financing Cash Flow Items -5.75-5.89-2.35-2.14
Issuance( Retirement)of Stock Net 2.650.002.981.32
Issuance( Retirement)of Debt Net 3.7912.298.9018.60
Cashfrom Financing Activities 0.696.419.5317.78
Net Changein Cash 0.06-0.13-2.432.46
Cash Interest Paid 5.755.892.352.14
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,504.70+44.10(1.79%)
1,921.85+32.70(1.73%)
589.05+6.30(1.08%)
11,105.00-351.85 (-3.07%)
HomeMarketsPremiumInstant LoanMint Shorts